POST Online Media Lite Edition



 

COVID-19: New clinical study realized with Belgian supplement shows promising results against COVID-19

Christian Fernsby |
New clinical study realized with a Belgian supplement shows promising results against COVID-19.

Article continues below




The study which was recently published in the leading journal in its field, Frontiers in Pharmacology, was a randomized controlled clinical trial conducted at the Department of Medicine, King Edward Medical University, Lahore, PK under the supervision of Dr. Amjad Khan, DPhil, M.Sc (Oxford), a Co-lead investigator of the study, and a Visiting Academic Researcher at the INEOS Oxford Institute for Antimicrobial Research, and Nuffield Division of Clinical and Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, UK.

The clinical trial compared the treatment effect of Nasafytol as add-on to the standard of care (SOC) vs SOC alone (control group) in the early-stage mild to moderately symptomatic RT-PCR confirmed COVID-19 outpatients.

The standard of care included paracetamol and/or antibiotic azithromycin. Patients in the Nasafytol group received two capsules twice a day for 14 days. Patients in both groups received the same SOC.

A total of 50 randomized patients (25 in each treatment group) completed the study. Patients who received the Nasafytol adjuvant therapy showed expedited negativization of the nasopharyngeal swab SARS-CoV-2 RT-PCR test at day 7, i.e; 15 (60.0%) vs 5 (20.0%) of the control group, p = 0.009.

COVID-19 associated acute symptoms were more rapidly resolved in the Nasafytol group at day 7, i.e; 15 (60.0%) vs 10 (40.0%) of the control group. Patients in the Nasafytol group showed a significant greater fall in the serum CRP levels at day 7, i.e; from medium34.0 to 11 mg/dL as compared to the control group, i.e; from 36.0 to 22.0 mg/dL, p = 0.006.

The Nasafytol adjuvant therapy was safe and well-tolerated by all 25 patients and no treatment emergent effects, complications, side-effects, or serious adverse events were reported.

Quercetin, and Curcumin, the two extensively studied natural polyphenols, reportedly possess broad-spectrum anti-viral, anti-inflammatory, immunomodulatory, and antioxidant pharmacological effects, and vitamin D3 is also a well-known immunomodulatory agent.

The inhibition of the SARS-CoV-2 viral replication and simultaneously modulation of the host hyper-inflammatory response in the early stage of COVID-19 infection is considered as crucial for the speedy recovery and prevention of progression to severe illness.

Quercetin and Curcumin have previously shown inhibition of coronaviruses in in vitro assays, and more recently have shown inhibitory activities against SARS-COV-2.

“The combination of Quercetin, Curcumin, and Vitamin D3 is a scientifically-backed safe adjuvant to treat COVID-19 in the early-stage; and the results shown by Nasafytol are very encouraging and likely due to effective synergistic immunomodulatory, antioxidant, anti-inflammatory and antiviral mechanisms of Quercetin, Curcumin and Vitamin D3”, said Dr. Amjad Khan.

The use of immunomodulatory/anti-inflammatory therapies in clinically vulnerable COVID-19 patients such as those with underlying health conditions or immunocompromised patients, may also cause immune-suppression, which can increase the risk of development of secondary bacterial or fungal infection and hence progression to severe illness.

On the contrary, Quercetin, Curcumin and Vitamin D3 naturally have no immune-suppression effect. Quercetin, and Curcumin are safe agents and have received the FDA GRASS (Generally Recognised As Safe) status for human use in dietary products.

In combination with routine care, the adjuvant use of Nasafytol may help in the speedier recovery of early-stage mild-to-moderately symptomatic COVID-19 infection, facilitated by early clearance of the SARS-CoV-2 viral infection and modulation of the immune response.


What to read next

Researchers uncover molecular mechanisms linked to autism and schizophrenia
New York State rolls out COVID-19 booster doses for eligible residents
India reports highest single day spike in new coronavirus cases, Philippines 653 more

Apollo Endosurgery to be acquired by Boston Scientific, enterprise value $615 million

 
Apollo Endosurgery announced it has entered into a definitive merger agreement to be acquired by Boston Scientific in an all-cash transaction with an enterprise value of approximately $615 million.
 
 

Latest

Poland: Criminal group extorted money making advantage of COVID situation
Sibanye-Stillwater begins construction of lithium hydroxide refinery in Finland
Switzerland's GDP grew by 0.2% in Q3 of 2022
Mexico's exports grow 19.5 pct

NEWS

UK: Christmas chaos ahead as Wiltshire parking wardens announce further strikes

Italy: 8 dead, several still missing after deadly Ischia mudslide
South Korea issues return-to-work order to truckers on strike
U.S.: Winter weather conditions for west, severe weather potential for south on Tuesday
World's largest volcano Mauna Loa erupts
WHO renames monkeypox as mpox on racism ground
 

BUSINESS

One in four U.S. workers still fear catching COVID at work, modest winter surge expected

No vessels left Ukrainian ports on November 28 due to adverse weather
Swedish nuclear reactor to be taken off-grid for repairs
UN and ILO must urgently intervene as South Korea weighs forcing striking drivers back to work, says ITF
More internationally educated family doctors on the way to British Columbia
Department of Health in South Africa to conduct feasibility study on implementing solar panels in hospitals
 

Trending Now

One in four U.S. workers still fear catching COVID at work, modest winter surge expected

Sibanye-Stillwater begins construction of lithium hydroxide refinery in Finland

Commission approves €557 million German support to compensate Deutsche Bahn

Apollo Endosurgery to be acquired by Boston Scientific, enterprise value $615 million


POLITICS

Tánaiste announces major change for small Irish companies

Commission approves €557 million German support to compensate Deutsche Bahn
Belgian government offers one-off tax-free bonus
Health minister discusses cooperation with French companies for manufacturing in Libya
Saudi Arabia unveils masterplan for mega Riyadh airport project
EU Parliament insists that EU must freeze funding to Hungary
 

Today We Recommend

One in four U.S. workers still fear catching COVID at work, modest winter surge expected


Highlights 

Apollo Endosurgery to be acquired by Boston Scientific, enterprise value $615 million

AstraZeneca to acquire Neogene Therapeutics for up to $320 mln

Shell to buy Nature Energy in £1.7bn deal


COMPANIES

Bechtel to build Intel's semiconductor manufacturing facilities in Ohio

Biocytogen Pharmaceuticals enters antibody agreement with ADC Therapeutics
BT announces plan for pay rise of up to 16% for all but highest paid
AstraZeneca to acquire Neogene Therapeutics for up to $320 mln
Shell to buy Nature Energy in £1.7bn deal
Africa Data Centres to build its first data centre in Kigali, Rwanda
 

CAREERS

US Foods appoints Dave Flitman as CEO

G Mining Ventures appoints Carlos Vilhena to board
Criterium Energy appoints David Dunlop as director
Arthex Biotech appoints Frédéric Legros as chairman
Promontory Therapeutics appoints Stanley J. Musial as CFO
1NCE expands leadership team in Europe and Asia-Pacific
 

ECONOMY

Trade between Bulgaria, North Macedonia to exceed EUR 1 Bln in 2022

EU trade with Indo-Pacific region
EU green energy product imports in 2021: 15.2 billion euros
Czech Republic: Economic sentiment ticks up in November
Poland: Business sentiment ticks up in November
Italy: Business confidence strengthens in November
 

EARNINGS

Natuzzi Q3 revenue increased 14.5%

CMA CGM Q3 revenue $19.9 billion
G. Willi-Food Q3 sales increased by 16.6%
Deere Q4 net income $2.246 billion
Nordstrom Q3 net loss $20 million
VMware Q3 revenue $3.21 billion
 

OP-ED

Micromanaging is the worst enemy of efficiency and teamwork

Niger set to monetize massive gas reserves through Saharan natural gas pipeline
Putting the brakes on EV folly that choked the market
Oil discovery in Kavango Basin may mean huge benefits for Namibians
Cape Town and Dubai battle over Africa's energy future
Is America going to lose its superpower status?
 

AGRIFISH

Colombian minister announces short and medium-term measures to help rural producers affected by winter weather

Third stage of vaccination against classical swine fever starts in Brazilian state Alagoas
Australia's fish stocks stable and steady
Australia pledges AUD 2 million to WTO Fisheries Funding Mechanism
Pesticide sales jump by 17% in Switzerland
Tesco announces close to £14 million of additional support for British egg industry
 

LEADERSHIP

Corporate duty waivers limit organic company growth and innovation

Women buy from women, men buy from women and men
How employee opinion impacts CEO dismissal
Keeping it in family can be good news when it comes to CEOs
Over a third of office workers are hybrid 'misfits'
Proxy advisers have inherent incentive to create controversy, study shows
 

CRIME

Meta Ireland fined 265 mln euros for data breach

Ukraine fines Engie, Shell subsidiaries over Nord Stream 2
New Zealand fines Southland fishing company $40,000
Italy's antitrust fines Edison Energia 3.8 mln euros over unfair practices
FTC secures monetary judgment in deceptive energy savings claims case
Croatian Competition Agency fines dairy processing company PIK Rijeka $13,740 for imposing unfair trading practices
 

Magazine

TRAVEL

Weather-resistant ArtWalk Downtown Billings, Montana

Dual branded Courtyard and Residence Inn by Marriott Hotel opens in Montreal
Candlewood Suites Hotel opens in Aberdeen, Md.
Mount Roraima, Venezuela, 7,671 feet above the forest floor
Llao Llao Resort, an exclusive resort in the middle of nowhere
Abu Dhabi welcomes visitors to discover experiences at their own pace
 

SEA, LAND, AIR

New colorful Porsche 718 Style Edition models

2023 Toyota Prius Prime, solar panel roof and reliability
Volvo EX90, a car with updates
Cessna Citation CJ4 Gen2 jet, pursue your business goals while enjoying journey
GMC first Sierra EV marks turning point
BMW M2, fast beast in small package
 

DESIGN

Patchwork carpets, vintage Persian carpets made with unparalleled skill

Real life wallpapers, perfectly executed
A. Lange & Söhne, men's watches with true Saxonian DNA
Nella Vetrina, luxurious Italian designers bathroom vanities and furniture
Karastan rugs, durable and beautiful
Leather bags for every occasion and every life style
 

GADGETS

Take Elektor Fortissimo and make your own high-end amplifier

RangeXTD, a Wi-Fi extender that actually works
Monitor II A.N.C. headphones, iconic Marshall sound
Zebra TC15, a clever mix of a mobile phone and a computer for business use
Bathroom speakers will make your relaxing even better
NAD 399 amplifier, highly efficient and remarkably powerful
 

HEALTH

Strong recommendation for pyronaridine-artesunate in revised WHO Malaria Treatment Guidelines

Pakistan launches anti-polio vaccination drive to inoculate 13.5 mln children
Ibuprofen and similar NSAIDS can be associated with hastened progression of osteoarthritis symptoms
Virgin Islands community encouraged to prevent antimicrobial resistance
Shionogi seeks Japan approval for COVID-19 vaccine
French doctors warn of antibiotics shortage
 

MEANTIME

Astrophysicists hunt for second-closest supermassive black hole

New European supercomputer inaugurated in Italy
European Space Agency presents new generation of astronauts
NASA selects Rocket Lab to launch TROPICS mission
World's heaviest flying bird heals itself with plants used in traditional medicine
James Webb Space Telescope reveals an exoplanet atmosphere as never seen before